© 2004 The Royal College of Psychiatrists
Hypothalamic-pituitary-adrenal axis function in patients with bipolar disorder
The Stanley Research Centre, University of Newcastle upon Tyne, The Royal Victoria Infirmary, Newcastle upon Tyne, UK
Department of Pathology & Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA
The Stanley Research Centre, University of Newcastle upon Tyne, The Royal Victoria Infirmary, Newcastle upon Tyne, UK
Correspondence: Professor A. H. Young, Department of Psychiatry, Leazes Wing, The Royal Victoria Infirmary, Queen Victoria Road, Newcastle upon Tyne NE1 4LP, UK. Tel: +44 (0)191 2824473; fax: +44 (0)191 2825708; e-mail: a.h.young{at}ncl.ac.uk
Declaration of interest Funded by the Stanley Medical Research Institute.
Background Hypothalamic-pituitary-adrenal (HPA) axis function, as variously measured by the responses to the combined dexamethasone/corticotrophin-releasing hormone (dex/CRH) test, the dexamethasone suppression test (DST) and basal cortisol levels, has been reported to be abnormal in bipolar disorder.
Aims To test the hypothesis that HPA axis dysfunction persists in patients in remission from bipolar disorder.
Method Salivary cortisol levels and the plasma cortisol response to the DST and dex/CRH test were examined in 53 patients with bipolar disorder, 27 of whom fulfilled stringent criteria for remission, and in 28 healthy controls. Serum dexamethasone levels were measured.
Results Patients with bipolar disorder demonstrated an enhanced cortisol response to the dex/CRH test compared with controls (P=0.001). This response did not differ significantly between remitted and non-remitted patients. These findings were present after the potentially confounding effects of dexamethasone levels were accounted for.
Conclusions The dex/CRH test is abnormal in both remitted and non-remitted patients with bipolar disorder. This measure of HPA axis dysfunction is a potential trait marker in bipolar disorder and thus possibly indicative of the core pathophysiological process in this illness.
Related articles in BJP:
- Highlights of this issue
BJP 2004 184: 465-a23.[Full Text]
This article has been cited by other articles:
 |
|
 |
|
  E. M. Prager and L. R. Johnson Stress at the Synapse: Signal Transduction Mechanisms of Adrenal Steroids at Neuronal Membranes Sci. Signal., September 1, 2009; 2(86): re5 - re5. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. McIsaac, A. Westrin, and A. H. Young Antiglucocorticoids in psychiatry Adv. Psychiatr. Treat., July 1, 2009; 15(4): 242 - 249. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. C. Padmos, M. H. J. Hillegers, E. M. Knijff, R. Vonk, A. Bouvy, F. J. T. Staal, D. de Ridder, R. W. Kupka, W. A. Nolen, and H. A. Drexhage A Discriminating Messenger RNA Signature for Bipolar Disorder Formed by an Aberrant Expression of Inflammatory Genes in Monocytes Arch Gen Psychiatry, April 1, 2008; 65(4): 395 - 407. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. KINGDON and A. H. YOUNG Research into putative biological mechanisms of mental disorders has been of no value to clinical psychiatry The British Journal of Psychiatry, October 1, 2007; 191(4): 285 - 290. [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Wei, E. K. Hebda-Bauer, A. Pletsch, J. Luo, M. T. Hoversten, A. J. Osetek, S. J. Evans, S. J. Watson, A. F. Seasholtz, and H. Akil Overexpressing the Glucocorticoid Receptor in Forebrain Causes an Aging-Like Neuroendocrine Phenotype and Mild Cognitive Dysfunction J. Neurosci., August 15, 2007; 27(33): 8836 - 8844. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Thompson, P. Gallagher, J. H. Hughes, S. Watson, J. M. Gray, I. N. Ferrier, and A. H. Young Neurocognitive impairment in euthymic patients with bipolar affective disorder The British Journal of Psychiatry, January 1, 2005; 186(1): 32 - 40. [Abstract] [Full Text] [PDF]
|
|